Code No. | Product | Discontinued date | Manufacturer |
---|---|---|---|
A07798 | Mouse IgG1 (isotype control)-PC5 | 2019/03/31 | BC |
A08932 | Anti-CD5 (Human) mAb-FITC | 2019/03/31 | BC |
A08933 | Anti-CD109 (Human) mAb-PE | 2019/03/31 | BC |
A08934 | Anti-CD314 (NKG2D) (Human) mAb-PE | 2019/03/31 | BC |
A09142 | Mouse IgG2a (isotype control)-PE | 2019/03/31 | BC |
A09144 | Mouse IgG2a (isotype control)-ECD | 2019/03/31 | BC |
A09148 | Mouse IgG2a (isotype control)-PC5 | 2019/03/31 | BC |
A09778 | Anti-CD158a, h (Human) mAb-PE | 2019/03/31 | BC |
A10974 | Mouse IgG1-FITC/Mouse IgG2a-PE mAb | 2019/03/31 | BC |
A12689 | Mouse IgG2a (isotype control) mAb-FITC | 2019/03/31 | BC |
A12692 | Mouse IgG2a (isotype control) mAb-PC7 | 2019/03/31 | BC |
A12693 | Mouse IgG2a (isotype control) mAb-APC | 2019/03/31 | BC |
A17599 | Mouse IgG1-FITC/Mouse IgG2a-PE mAb | 2019/03/31 | BC |
A21689 | Anti-CD2 (Human) mAb-PC7 | 2019/03/31 | BC |
A21690 | Anti-CD5 (Human) mAb-PC7 | 2019/03/31 | BC |
A21691 | Anti-CD34 (Human) mAb-PC7 | 2019/03/31 | BC |
A21692 | Anti-CD56 (Human) mAb-PC7 | 2019/03/31 | BC |
A21693 | Anti-CD20 (Human) mAb-APC | 2019/03/31 | BC |
A22327 | Anti-Cyclin A2 (Human) mAb-FITC | 2019/03/31 | BC |
A22328 | Anti-CD300a (IRp60) (Human) mAb-PE | 2019/03/31 | BC |
A22329 | Anti-CD314 (NKG2D) (Human) mAb-APC | 2019/03/31 | BC |
A22330 | Anti-p75 (AIRM1) (Human) mAb-PE | 2019/03/31 | BC |
A22331 | Anti-CD14 (Human) mAb-PC7 | 2019/03/31 | BC |
A22332 | Anti-CD158a, h (Human) mAb-APC | 2019/03/31 | BC |
A22333 | Anti-CD158b1/b2, j (Human) mAb-APC | 2019/03/31 | BC |
A22334 | Anti-CD85d (ILT4) (Human) mAb-PE | 2019/03/31 | BC |
A22360 | Anti-CD120b (TNF-R2) (Human) mAb-PE | 2019/03/31 | BC |
A22361 | Anti-CD166 (ALCAM) (Human) mAb-PE | 2019/03/31 | BC |
A22364 | Anti-CD146 (Human) mAb-PC5 | 2019/03/31 | BC |
A23413 | Dendritic Cells "Myeliod Subset" CD14+CD16-FITC/CD85k-PE/CD33-PC5 | 2019/03/31 | BC |
A23416 | Dendritic Cells "Plasmacytoid Subset" CD14+16-FITC/CD85k-PE/CD123-PC5 | 2019/03/31 | BC |
A24987 | Anti-OSCAR mAb-PE | 2019/03/31 | BC |
A32535 | Anti-CD123 mAb-PE | 2019/03/31 | BC |
A32536 | Anti-CD21 mAb-PE | 2019/03/31 | BC |
A32537 | Anti-CD44 mAb-PE | 2019/03/31 | BC |
A32560 | Anti-CD43 mAb-PE | 2019/03/31 | BC |
A33096 | Anti-CD5 mAb-&beta:gal | 2019/03/31 | BC |
A33098 | Anti-CD16 mAb-ECD | 2019/03/31 | BC |
A33099 | Anti-CD23 mAb-PE | 2019/03/31 | BC |
A39499 | Anti-TCR Pan α/β (Human) mAb-PE | 2019/03/31 | BC |
A39500 | Anti-TCR Pan α/β (Human) mAb-PC5 | 2019/03/31 | BC |
A40174 | Anti-IgE (D ε2) (Human) mAb | 2019/03/31 | BC |
A40316 | Anti-CD138 (Syndecan-1) (Human) mAb-PE | 2019/03/31 | BC |
A40579 | Anti-HLA-DR (Human) mAb-PC7 | 2019/03/31 | BC |
A40926 | Anti-NTB-A (Human) mAb-PE | 2019/03/31 | BC |
A44226 | Anti-CD85a (ILT5) (Human) mAb-PE | 2019/03/31 | BC |
A46526 | Anti-CD7 (Human) mAb-PC7 | 2019/03/31 | BC |
A46527 | Anti-CD10 (Human) mAb-PC7 | 2019/03/31 | BC |
A46528 | Anti-CD13 (Human) mAb-PC7 | 2019/03/31 | BC |
A46529 | Anti-CD85k (ILT3) (Human) mAb-PC7 | 2019/03/31 | BC |
A49080 | Anti-CD278 (ICOS) (Human) mAb-PE | 2019/03/31 | BC |
A52635 | Anti-NKp80 (Human) mAb-PE | 2019/03/31 | BC |
A52882 | Anti-CD25 (Human) mAb-PC7 | 2019/03/31 | BC |
A53365 | Anti-CD122 (IL-2Rβ) (Human) mAb-PC7 | 2019/03/31 | BC |
A54139 | Anti-CD45 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A54189 | Anti-CD38 (Human) mAb-PC7 | 2019/03/31 | BC |
A54191 | Anti-CD138 (Human) mAb-PC5 | 2019/03/31 | BC |
A54822 | Anti-CD11b (Human) mAb-PC7 | 2019/03/31 | BC |
A54823 | Anti-CD27 (Human) mAb-PC7 | 2019/03/31 | BC |
A54824 | Anti-CD33 (Human) mAb-PC7 | 2019/03/31 | BC |
A60790 | Anti-CD5 (Human) mAb-APC | 2019/03/31 | BC |
A60791 | Anti-CD22 (Human) mAb-APC | 2019/03/31 | BC |
A60792 | Anti-CD38 (Human) mAb-APC | 2019/03/31 | BC |
A60794 | Anti-CD2 (Human) mAb-APC | 2019/03/31 | BC |
A60795 | Anti-CD158e1/e2 (Human) mAb-APC | 2019/03/31 | BC |
A60796 | Anti-CD158i (Human) mAb-APC | 2019/03/31 | BC |
A60797 | Anti-CD159a (Human) mAb-APC | 2019/03/31 | BC |
A62834 | Mouse IgG1 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A63663 | Anti-TCR Vγ9 (Human) mAb-PC5 | 2019/03/31 | BC |
A64615 | Anti-CD309 (Human) mAb-PE | 2019/03/31 | BC |
A64616 | Anti-CD309 (Human) mAb-PC7 | 2019/03/31 | BC |
A64617 | Anti-CD127 (Human) mAb-PC5 | 2019/03/31 | BC |
A64618 | Anti-CD127 (Human) mAb-PC7 | 2019/03/31 | BC |
A64827 | Anti-λ (Human) pAb-PE | 2019/03/31 | BC |
A64828 | Anti-Igκ (Human) pAb-FITC | 2019/03/31 | BC |
A66085 | Anti-CD106 (Human) mAb-PE | 2019/03/31 | BC |
A66327 | Anti-CD3 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A66328 | Anti-CD19 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A66329 | Anti-CD3 (Human) mAb-APC-Alexa Fluor® 750 | 2019/03/31 | BC |
A66330 | Anti-CD16 (Human) mAb-APC-Alexa Fluor® 750 | 2019/03/31 | BC |
A66331 | Anti-CD20 (Human) mAb-APC-Alexa Fluor® 750 | 2019/03/31 | BC |
A66332 | Anti-CD8 (Human) mAb-APC-Alexa Fluor® 700 | 2019/03/31 | BC |
A66333 | Anti-CD117 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A66898 | Anti-CD158a, h (Human) mAb-PC5.5 | 2019/03/31 | BC |
A66899 | Anti-CD158a, h (Human) mAb-PC7 | 2019/03/31 | BC |
A66900 | Anti-CD158b1/b2, j (Human) mAb-PC5.5 | 2019/03/31 | BC |
A66901 | Anti-CD158b1/b2, j (Human) mAb-PC7 | 2019/03/31 | BC |
A66902 | Anti-CD335 (NKp46) (Human) mAb-PC5 | 2019/03/31 | BC |
A66903 | Anti-CD336 (NKp44) (Human) mAb-PC5 | 2019/03/31 | BC |
A66904 | Anti-CD337 (NKp30) (Human) mAb-PC5 | 2019/03/31 | BC |
A66905 | Anti-TCR Vβ11 (Human) mAb-APC | 2019/03/31 | BC |
A66907 | Anti-TCR Vα24 (Human) mAb-PC7 | 2019/03/31 | BC |
A69964 | Anti-CD23 (Human) mAb-APC | 2019/03/31 | BC |
A70200 | Anti-CD33 (Human) mAb-APC-Alexa Fluor® 750 | 2019/03/31 | BC |
A70202 | Anti-CD7 (Human) mAb-ECD | 2019/03/31 | BC |
A70203 | Anti-CD5 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A70204 | Anti-CD14 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A70205 | Anti-CD38 (Human) mAb-PC5.5 | 2019/03/31 | BC |
A70207 | Anti-CD23 (Human) mAb-APC-Alexa Fluor® 700 | 2019/03/31 | BC |
A71116 | Anti-CD127 (Human) mAb-APC-Alexa Fluor® 700 | 2019/03/31 | BC |